Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-005120
Filing Date
2023-03-17
Accepted
2023-03-17 16:30:16
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 form4-03172023_040301.html 4  
1 form4-03172023_040301.xml 4 15565
  Complete submission text file 0001415889-23-005120.txt   16850
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 23743034